Literature DB >> 7558924

A computer program for predicting possible cytotoxic T lymphocyte epitopes based on HLA class I peptide-binding motifs.

J D'Amaro1, J G Houbiers, J W Drijfhout, R M Brandt, R Schipper, J N Bavinck, C J Melief, W M Kast.   

Abstract

Vaccination with peptides recognized by antigen-specific CTLs can prevent lethal virus infections and tumor growth. In order to avoid the synthesis and testing of the numerous overlapping peptide of long AA sequences of proteins of interest, we developed a computer program which utilizes the rules, "motifs" which govern how peptides bind to HLA class I molecules, to derive a predicted binding score for each overlapping peptide. Correlations between the predicted and actual binding results to HLA-A*0201 for 100 peptides selected from six early and two late protein sequences of human papillomavirus type 1a revealed an acceptable level (61%) of concordance. The program is very flexible with regard to the input of protein sequences and motif definitions and is able to handle various motif and peptide lengths.

Entities:  

Mesh:

Substances:

Year:  1995        PMID: 7558924     DOI: 10.1016/0198-8859(94)00153-h

Source DB:  PubMed          Journal:  Hum Immunol        ISSN: 0198-8859            Impact factor:   2.850


  15 in total

1.  Recovery of known T-cell epitopes by computational scanning of a viral genome.

Authors:  Antoine Logean; Didier Rognan
Journal:  J Comput Aided Mol Des       Date:  2002-04       Impact factor: 3.686

2.  The use of bovine MHC class I allele-specific peptide motifs and proteolytic cleavage specificities for the prediction of potential cytotoxic T lymphocyte epitopes of bovine viral diarrhea virus.

Authors:  N R Hegde; S Srikumaran
Journal:  Virus Genes       Date:  1997       Impact factor: 2.332

3.  Prediction of potential cytotoxic T lymphocyte epitopes of bovine herpesvirus 1 based on allele-specific peptide motifs and proteolytic cleavage specificities.

Authors:  N R Hegde; S Srikumaran
Journal:  Virus Genes       Date:  1996       Impact factor: 2.332

4.  Perioperative blood transfusions increase infectious complications after ileoanal pouch procedures (IPAA).

Authors:  Khaled M Madbouly; Anthony J Senagore; Feza H Remzi; Conor P Delaney; Jonathan Waters; Victor W Fazio
Journal:  Int J Colorectal Dis       Date:  2006-04-01       Impact factor: 2.571

5.  Proteomics in Vaccinology and Immunobiology: An Informatics Perspective of the Immunone.

Authors:  Irini A. Doytchinova; Paul Taylor; Darren R. Flower
Journal:  J Biomed Biotechnol       Date:  2003

Review 6.  Diagnosis and management of human cytomegalovirus infection in the mother, fetus, and newborn infant.

Authors:  Maria Grazia Revello; Giuseppe Gerna
Journal:  Clin Microbiol Rev       Date:  2002-10       Impact factor: 26.132

7.  CD8 T cell autoreactivity to preproinsulin epitopes with very low human leucocyte antigen class I binding affinity.

Authors:  J R F Abreu; S Martina; A A Verrijn Stuart; Y E Fillié; K L M C Franken; J W Drijfhout; B O Roep
Journal:  Clin Exp Immunol       Date:  2012-10       Impact factor: 4.330

8.  EGFR-specific T cell frequencies correlate with EGFR expression in head and neck squamous cell carcinoma.

Authors:  Patrick J Schuler; Petra Boeckers; Rainer Engers; Edwin Boelke; Murat Bas; Jens Greve; Claudia A Dumitru; Goetz F Lehnerdt; Robert L Ferris; Pedro A Andrade Filho; Sven Brandau; Stephan Lang; Theresa L Whiteside; Thomas K Hoffmann
Journal:  J Transl Med       Date:  2011-10-04       Impact factor: 5.531

9.  Simultaneous humoral and cellular immune response against cancer-testis antigen NY-ESO-1: definition of human histocompatibility leukocyte antigen (HLA)-A2-binding peptide epitopes.

Authors:  E Jäger; Y T Chen; J W Drijfhout; J Karbach; M Ringhoffer; D Jäger; M Arand; H Wada; Y Noguchi; E Stockert; L J Old; A Knuth
Journal:  J Exp Med       Date:  1998-01-19       Impact factor: 14.307

Review 10.  T-cell epitope vaccine design by immunoinformatics.

Authors:  Atanas Patronov; Irini Doytchinova
Journal:  Open Biol       Date:  2013-01-08       Impact factor: 6.411

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.